Trastuzumab Pregnancy and Breastfeeding Warnings
Trastuzumab is also known as: Herceptin
Trastuzumab Pregnancy Warnings
Trastuzumab has been assigned to pregnancy category D by the FDA. Animal studies have revealed that in mutant mice lacking HER2, embryos died in early gestation. There are no controlled data in human pregnancy. Postmarketing case reports suggest that trastuzumab use during pregnancy increases the risk of oligohydramnios during the second and third trimesters. Trastuzumab is only recommended for use during pregnancy when there are no alternatives and benefit outweighs risk.
A case has been reported of a woman who received three cycles of trastuzumab during her first trimester and had no complications.
Trastuzumab Breastfeeding Warnings
There are no data on the excretion of trastuzumab into human milk. Because human IgG is excreted in human milk and because of the potential for serious adverse reactions due to trastuzumab in nursing infants, women are advised to discontinue nursing during trastuzumab therapy and for six months after the last dose of trastuzumab.
See Also...
- trastuzumab Consumer Information
- Pregnancy Support Group
- FDA Pregnancy Categories
- Medicine use during Pregnancy
- Medicine use while Breastfeeding
- Safe Medications during Breastfeeding
Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This drug information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.
